Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 7/20 | 0.48 |
| ▸ | CA2 | P00918 | 7/20 | 0.48 |
| ▸ | CA12 | O43570 | 5/20 | 0.48 |
| ▸ | CA7 | P43166 | 5/20 | 0.48 |
| ▸ | CA9 | Q16790 | 5/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | HPGD | P15428 | 3/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | ESR1 | P03372 | 3/20 | 0.38 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27602847 | 1.00 | CA1 (0.48) | CA1CA2CA12CA7CA9 | |
| SCHEMBL8819049 | 0.84 | TSHR (0.47) | ALDH1A1MAPTHPGDCYP3A4TDP1 | |
| SCHEMBL563939 | 0.84 | TSHR (0.47) | ALDH1A1MAPTHPGDCYP3A4TDP1 | |
| SCHEMBL8539430 | 0.84 | TSHR (0.47) | ALDH1A1MAPTHPGDCYP3A4TDP1 | |
| SCHEMBL9043211 | 0.82 | CA1 (0.52) | CA1CA2CA12CA7CA9 | |
| SCHEMBL9043204 | 0.82 | CA1 (0.52) | CA1CA2CA12CA7CA9 | |
| SCHEMBL9659551 | 0.82 | CA1 (0.52) | CA1CA2CA12CA7CA9 | |
| SCHEMBL9659492 | 0.80 | CA1 (0.48) | CA1CA2CA12CA7CA9 | |
| SCHEMBL9659486 | 0.80 | CA1 (0.48) | CA1CA2CA12CA7CA9 | |
| SCHEMBL27585032 | 0.80 | CA1 (0.44) | CA1CA2CA12CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040186318-A1 | Method for producing (2e)-2-(hydroxyphenyl-2-(alkoxyimino)-n-methylacetamides | BAYER CROPSCIENCE AG (DE) | 2004-09-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040186318-A1 | Method for producing (2e)-2-(hydroxyphenyl-2-(alkoxyimino)-n-methylacetamides | HMOX2, CYP1A2, PTGS2 | CA1 1377/4885CA2 934/4885CA12 1990/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.